Cover Image

Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice

Huashan Li,1,* Jianying Sheng,1,* Jing Wang,1 Haiting Gao,1 Jing Yu,2 Guoxian Ding,2 Ning Ding,1 Weiqi He,1,3 Juanmin Zha1 1Jiangsu Key Laboratory of Neuropsychiatric Diseases and Cambridge-Suda (CAM-SU) Genomic Resource Center, Medical College of Soochow University, Department of Oncology, The Firs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Li H (Author), Sheng J (Author), Wang J (Author), Gao H (Author), Yu J (Author), Ding G (Author), Ding N (Author), He W (Author), Zha J (Author)
Format:	Book
Published:	Dove Medical Press, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Luteinizing hormone induces expression of 11beta-hydroxysteroid dehydrogenase type 2 in rat Leydig cells
by: Zhang Ping, et al.
Published: (2009)

Luteal 3beta-hydroxysteroid dehydrogenase and 20alpha-hydroxysteroid dehydrogenase activities in the rat corpus luteum of pseudopregnancy: Effect of the deciduoma reaction
by: Telleria Carlos M, et al.
Published: (2004)

Mitochondrial 3 beta-hydroxysteroid dehydrogenase (HSD) is essential for the synthesis of progesterone by corpora lutea: An hypothesis
by: Polanco Jose R, et al.
Published: (2005)

Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
by: Louis Fabio Jonathan Jusni, et al.
Published: (2021)

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
by: Zuo Q, et al.
Published: (2022)

Human type 2 17beta-hydroxysteroid dehydrogenase mRNA and protein distribution in placental villi at mid and term pregnancy
by: Plante Julie, et al.
Published: (2007)

Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects
by: Susan Bellaire, et al.
Published: (2019)

Can Resveratrol Influence the Activity of 11β-Hydroxysteroid Dehydrogenase Type 1? A Combined In Silico and In Vivo Study
by: Jurica Novak, et al.
Published: (2023)

5-Bis-(2,6-difluoro-benzylidene) Cyclopentanone Acts as a Selective 11β-Hydroxysteroid Dehydrogenase one Inhibitor to Treat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
by: Hongguo Guan, et al.
Published: (2021)

Case Report:clinical experience of bilateral giant pediatric Testicular adrenal rest tumors with 3 Beta-Hydroxysteroid Dehydrogenase-2 family history
by: Lingyun Yu, et al.
Published: (2021)

An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells
by: Ling-Ling Chang, et al.
Published: (2018)

siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo
by: Li F, et al.
Published: (2019)

The role of 11?-hydroxysteroid dehydrogenase type 1 and type2 isoenzymes on the pathogenesis of Cushing's syndrome - doi:10.5020/18061230.2007.p104
by: Maria Betânia Pereira Toralles, et al.
Published: (2012)

Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway
by: You Zhang, et al.
Published: (2023)

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
by: Terry D. Hinds, et al.
Published: (2020)

Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis
by: Yaoling Shu, et al.
Published: (2021)

Physical training at sub-threshold intensity reduces the prevalence of hepatic steatosis after high-fat diet in rats
by: Valdemar Guedes da Silva, et al.
Published: (2015)

Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as Potential Drugs for Type 2 Diabetes Mellitus-A Systematic Review of Clinical and In Vivo Preclinical Studies
by: Cristiana Almeida, et al.
Published: (2021)

URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice
by: Yoshiro Tanaka, et al.
Published: (2022)

Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond
by: Ting Tai, et al.
Published: (2024)

Preventing High Fat Diet-Induced Obesity and Related Hepatic Steatosis by Chlorin e6-Mediated Photodynamic Therapy
by: Pallavi Gurung, et al.
Published: (2024)

Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis
by: Qiongyu Lu, et al.
Published: (2023)

High-fat diet enhanced retinal dehydrogenase activity, but suppressed retinol dehydrogenase activity in liver of rats
by: Mian Zhang, et al.
Published: (2015)

Inhibitory Effect of Periodontitis through C/EBP and 11β-Hydroxysteroid Dehydrogenase Type 1 Regulation of Betulin Isolated from the Bark of <i>Betula platyphylla</i>
by: Eun-Nam Kim, et al.
Published: (2022)

Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
by: Hung-Jen Lin, et al.
Published: (2017)

Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages
by: Sung Bum Park, et al.
Published: (2016)

Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy-lysosomal pathway
by: Xiliang Du, et al.
Published: (2022)

The Curcumin Derivative, H10, Suppresses Hormone-Dependent Prostate Cancer by Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3
by: Yating Cheng, et al.
Published: (2020)

Identification of a Novel Mutation in an Iranian Family With 17-β Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Series
by: Abolfazl Heidari, et al.
Published: (2022)

MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice
by: Christian Smolka, et al.
Published: (2021)

High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
by: Jutatip Kaewmalee, et al.
Published: (2021)

Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy
by: Shuyi Wang, et al.
Published: (2021)

Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway
by: Mi Rim Lee, et al.
Published: (2020)

Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice
by: Li L, et al.
Published: (2021)

Protective Effect of Patchouli Alcohol Against High-Fat Diet Induced Hepatic Steatosis by Alleviating Endoplasmic Reticulum Stress and Regulating VLDL Metabolism in Rats
by: Xue Wu, et al.
Published: (2019)

Abdominal fat index - a non-invasive marker of hepatic steatosis and insulin resistance in children
by: N.Yu. Zavhorodnia, et al.
Published: (2017)

Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance
by: Lia R. Edmunds, et al.
Published: (2020)

Reduced Liver Autophagy in High-Fat Diet Induced Liver Steatosis in New Zealand Obese Mice
by: Ioanna Korovila, et al.
Published: (2021)

Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression
by: Xiyue Shen, et al.
Published: (2023)

Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
by: Ting-Chen Chang, et al.
Published: (2019)